Shanghai Celgen Bio-Pharmaceutical Co., Ltd.

Follow

Organization

Shanghai, CN

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Fusion protein inhibiting TACI-BAFF complex formation and preparati...
- Patent number 10,562,954
- Issue date Feb 18, 2020
- Shanghai Kanda Biotechnology Co., Ltd.
- Zeling Cai
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
MONOCLONAL ANTIBODY TARGETING TIGIT
- Publication number 20240417462
- Publication date Dec 19, 2024
- Shanghai Celgen Bio-Pharmaceutical Co., Ltd.
- Yi CHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSION PROTEIN OF ANTI-TIGIT ANTIBODY AND IL2 OR VARIANT THEREOF AN...
- Publication number 20240400680
- Publication date Dec 5, 2024
- Shanghai Celgen Bio-Pharmaceutical Co., Ltd.
- Yi CHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-TNFR2 MONOCLONAL ANTIBODY AND APPLICATION THEREOF
- Publication number 20240392024
- Publication date Nov 28, 2024
- Shanghai Celgen Bio-Pharmaceutical Co., Ltd.
- Zeling CAI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSION PROTEIN OF TNFR2 AND APRIL BAFF RECEPTOR
- Publication number 20240150432
- Publication date May 9, 2024
- Shanghai Celgen Bio-Pharmaceutical Co., Ltd.
- Zeling CAI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSION PROTEIN INHIBITING TACI-BAFF COMPLEX FORMATION AND PREPARATI...
- Publication number 20170081387
- Publication date Mar 23, 2017
- Shanghai Kanda Biotechnology Co., Ltd.
- Zeling Cai
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Trademarklast 30 trademarks